gemini-2.5-flash-lite-preview-09-2025| input-price: 0.1 output-price: 0.4 max-context-length: 128_000 (cost: $0.008) · Anfrage: 2025-10-20T07:25:04.473007

Generated by rs-summarizer Version unbekannt

Abstract:

This presentation, "CPC Session One," by Jared Gardner, covers the differential diagnosis and pathology of several challenging soft tissue tumors, emphasizing the importance of clinicopathologic correlation and appropriate ancillary testing.

The session details four primary cases:

  1. Case 1: Fibrosarcomatous Dermatofibrosarcoma Protuberans (DFSP): A well-circumscribed nodule mimicking fibrosarcoma due to its cellular, herringbone pattern, but distinguished by its strong CD34 positivity and a rare $PDGFD$ gene rearrangement in the absence of the typical $COL1A1-PDGFB$ fusion.
  2. Case 2: Epithelioid Fibrous Histiocytoma (EFH): A superficial, dome-shaped papule with a collarette, characterized by epithelioid cells, often exhibiting signet-ring change, and confirmed by $ALK1$ gene fusion/expression. A tip on using the D5F3 $ALK1$ clone for better staining is provided.
  3. Case 3: Cutaneous Sheet-like Myoepithelioma: A lesion that showed an overlap in markers ($EMA+$ and $S100+$) but was definitively diagnosed as a cutaneous sheet-like myoepithelioma (a variant of myoepithelioma) based on the presence of an $EWSR1-PBX3$ fusion and negativity for the $ALK1$ gene rearrangement by FISH.
  4. Case 4: Alveolar Rhabdomyosarcoma (RMS): A highly worrisome, cellular, round blue cell tumor in a young patient that was nearly misdiagnosed as Merkel cell carcinoma due to focal keratin and neuroendocrine staining. The diagnosis was secured by positive desmin and strong myogenin expression, confirming it as an aggressive RMS (specifically alveolar subtype), despite its rare presentation in the skin of an older adult.

The session concludes with further cases in CPC Session Two, highlighting the diagnostic pitfalls and key molecular markers necessary for accurate classification of complex spindle cell and round blue cell tumors.

Key Takeaways from CPC Session One (Cases 1-4):

Summary Rating: No ratings yet
Article Rating: No ratings yet

Source